Published in Women's Health Weekly, May 1st, 2006
According to a study from Italy, "The endogenous cannabinoid anandamide (AEA) plays important roles in modulating pain. Head pain is an almost universal human experience, yet primary headache disorders, such as migraine without aura (MoA) or episodic tension-type headache (ETTH), can represent a serious threat to well-being when frequent and disabling."
"We assessed the discriminating role of endocannabinoids among patients with ETTH or MoA, and control subjects," stated L.M. Cupini and colleagues of S. Eugenio Hospital in Rome. "We measured the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly